Dorman Products INC (DORM) Stock Rose While Rice Hall James & Associates LLC Trimmed Its Stake

November 21, 2017 - By Adrian Erickson

Investors sentiment increased to 1.23 in Q2 2017. Its up 0.20, from 1.03 in 2017Q1. It improved, as 17 investors sold DORM shares while 76 reduced holdings. 33 funds opened positions while 81 raised stakes. 25.28 million shares or 2.44% less from 25.91 million shares in 2017Q1 were reported. Barclays Public Ltd Co has invested 0% of its portfolio in Dorman Products Inc. (NASDAQ:DORM). New York-based Alliancebernstein LP has invested 0% in Dorman Products Inc. (NASDAQ:DORM). Northern Trust stated it has 495,067 shares or 0.01% of all its holdings. Dimensional Fund Advsr Ltd Partnership reported 0.03% stake. Geode Cap Mgmt Ltd Liability Co owns 0.01% invested in Dorman Products Inc. (NASDAQ:DORM) for 260,812 shares. Pacad Limited stated it has 0.04% in Dorman Products Inc. (NASDAQ:DORM). Shine Investment Advisory Serv holds 0.01% or 134 shares in its portfolio. Thrivent Fincl For Lutherans holds 18,250 shares. 5,823 are held by Atria Limited Liability. 139,577 are held by Fiera Capital. Tiaa Cref Management Lc holds 0% of its portfolio in Dorman Products Inc. (NASDAQ:DORM) for 73,917 shares. Citigroup Incorporated has invested 0% in Dorman Products Inc. (NASDAQ:DORM). Ny State Teachers Retirement holds 17,835 shares. State Of Wisconsin Inv Board invested in 92,300 shares or 0.02% of the stock. Eulav Asset Mgmt has invested 0.02% in Dorman Products Inc. (NASDAQ:DORM).

Rice Hall James & Associates Llc decreased its stake in Dorman Products Inc. (DORM) by 20.05% based on its latest 2017Q2 regulatory filing with the SEC. Rice Hall James & Associates Llc sold 54,434 shares as the company’s stock rose 14.29% with the market. The institutional investor held 217,079 shares of the capital goods company at the end of 2017Q2, valued at $17.97 million, down from 271,513 at the end of the previous reported quarter. Rice Hall James & Associates Llc who had been investing in Dorman Products Inc. for a number of months, seems to be less bullish one the $2.35 billion market cap company. The stock rose 0.34% or $0.24 reaching $69.61. About 51,019 shares traded. Dorman Products Inc. (NASDAQ:DORM) has risen 57.51% since November 21, 2016 and is uptrending. It has outperformed by 40.81% the S&P500.

Rice Hall James & Associates Llc, which manages about $1.51 billion and $2.30 billion US Long portfolio, upped its stake in Integrated Device Technology (NASDAQ:IDTI) by 133,664 shares to 1.51M shares, valued at $39.03 million in 2017Q2, according to the filing. It also increased its holding in Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) by 267,971 shares in the quarter, for a total of 1.36 million shares, and has risen its stake in Emergent Biosolutions Inc. (NYSE:EBS).

Analysts expect Dorman Products Inc. (NASDAQ:DORM) to report $0.86 EPS on February, 28.They anticipate $0.03 EPS change or 3.61 % from last quarter’s $0.83 EPS. DORM’s profit would be $29.04M giving it 20.23 P/E if the $0.86 EPS is correct. After having $0.80 EPS previously, Dorman Products Inc.’s analysts see 7.50 % EPS growth.

More notable recent Dorman Products Inc. (NASDAQ:DORM) news were published by: Nasdaq.com which released: “Dorman Products, Inc. Announces Date to Report Sales and Earnings for the …” on October 16, 2017, also Reuters.com with their article: “BRIEF-Dorman Products announces the acquisition of MAS Automotive Distribution” published on October 27, 2017, Globenewswire.com published: “Dorman Products, Inc. Announces the Appointment of Kelly Romano to its Board …” on November 09, 2017. More interesting news about Dorman Products Inc. (NASDAQ:DORM) were released by: Nasdaq.com and their article: “Dorman Products Enters Oversold Territory (DORM)” published on November 09, 2017 as well as Globenewswire.com‘s news article titled: “Dorman Products, Inc. Reports Sales and Earnings for the Second Quarter Ended …” with publication date: August 01, 2017.

Dorman Products Inc. (NASDAQ:DORM) Ratings Coverage

Among 7 analysts covering Dorman Products (NASDAQ:DORM), 2 have Buy rating, 0 Sell and 5 Hold. Therefore 29% are positive. Dorman Products had 15 analyst reports since October 14, 2015 according to SRatingsIntel. The stock of Dorman Products Inc. (NASDAQ:DORM) earned “Hold” rating by Jefferies on Thursday, July 6. The rating was initiated by Sidoti on Wednesday, December 23 with “Buy”. The firm earned “Hold” rating on Monday, September 11 by Jefferies. The stock of Dorman Products Inc. (NASDAQ:DORM) earned “Hold” rating by Jefferies on Wednesday, August 9. FBR Capital maintained Dorman Products Inc. (NASDAQ:DORM) rating on Thursday, October 29. FBR Capital has “Outperform” rating and $62 target. The firm earned “Mkt Perform” rating on Thursday, February 23 by FBR Capital. On Tuesday, October 20 the stock rating was initiated by Jefferies with “Hold”. Jefferies maintained Dorman Products Inc. (NASDAQ:DORM) on Wednesday, July 27 with “Hold” rating. As per Thursday, October 15, the company rating was downgraded by BB&T Capital. The rating was initiated by Barrington Research with “Outperform” on Wednesday, October 14.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.